TD Cowen Maintains Buy on Charles River, Raises Price Target to $325

9/25/2026
Impact: 80
Healthcare

TD Cowen analyst Charles Rhyee has maintained a Buy rating on Charles River (NYSE: CRL) and increased the price target from $300 to $325. This adjustment reflects a positive outlook for the company's performance in the market.

AI summary, not financial advice

Share: